
27 November 2008: Announcement no. 3, 2008: Zealand Pharma and Helsinn Healthcare S...
Zealand's Pipeline comprises 1 compound in phase III, 1 compound in phase II, 2 c...
29 November 2002:
Zealand Pharma announces successful Phase I trials for ZP120 in acute heart failure
18 September 2002:
Zealand Pharma reports successful phase I/IIa trial with ZP10 in type 2 diabetes patients
12 June 2002:
Zealand increases focus on Gap Junctions
4 April 2002:
Zealand in Clinical Trials with Aquaretic Compound